<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-116077</identifier>
<setSpec>0211-5735</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Perimenopausal depression: a review</dc:title>
<dc:description xml:lang="en">From adolescence, women have a 1.5 to 3 times higher risk than men of suffering from a depressive disorder. This risk increases in the transition period to menopause or perimenopause, when the depressive vulnerability becomes especially intense. Hormonal, psychological and sociocultural factors have been suggested to understand the etiopathogeny of these disorders. Treatment of depression in perimenopause is determined by clinical severity and includes antidepressants, psychotherapy, and sometimes, hormone replacement therapy with estrogens. Perimenopausal depression is an underdiagnosed and poorly treated problem, which generates a high level of suffering and deserves greater attention by clinicians and health systems (AU)</dc:description>
<dc:creator>Gonzalez Torres, Miguel Ángel</dc:creator>
<dc:creator>Sesma Pardo, Eva</dc:creator>
<dc:creator>Finkle, Joshua</dc:creator>
<dc:creator>Gaviria, Moisés</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">A partir de la adolescencia, las mujeres presentan un riesgo 1&#146;5 a 3 veces mayor que los hombres de padecer un trastorno depresivo. Este riesgo aumenta en el periodo de transición hacia la menopausia o perimenopausia, cuando la vulnerabilidad depresiva se hace especialmente intensa. Se han postulado mecanismos hormonales, psicológicos y socioculturales para entender la etiopatogenia de estos cuadros. El tratamiento de la depresión en la perimenopausia viene determinado por la gravedad clínica e incluye antidepresivos, psicoterapia y, en ocasiones, terapia hormonal sustitutiva mediante estrógenos. La depresión perimenopáusica constituye un problema infradiagnosticado e infratratado, que genera un alto nivel de sufrimiento y que merece una mayor atención por parte de los clínicos y el sistema sanitario (AU)</dc:description>
<dc:source>Rev. Asoc. Esp. Neuropsiquiatr;33(120): 681-691, sept.-dic. 2013. tab</dc:source>
<dc:identifier>ibc-116077</dc:identifier>
<dc:title xml:lang="es">Depresión perimenopáusica: una revisión</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d3883^s22054</dc:subject>
<dc:subject>^d3883^s22032</dc:subject>
<dc:subject>^d38867^s22031</dc:subject>
<dc:subject>^d3883^s22056</dc:subject>
<dc:subject>^d38867^s22021</dc:subject>
<dc:subject>^d3487</dc:subject>
<dc:subject>^d38867^s22056</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d12049^s22048</dc:subject>
<dc:subject>^d13306^s22066</dc:subject>
<dc:subject>^d12049^s22049</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d12049^s22045</dc:subject>
<dc:subject>^d3883^s22080</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:type>article</dc:type>
<dc:date>201312</dc:date>
</metadata>
</record>
</ibecs-document>
